Published in Gene Therapy Weekly, July 3rd, 2003
Microbubbles are used as contrast agents for ultrasound imaging and are particularly valuable for targeting selected tissues and for providing useful information about the efficacy of chemotherapy. Medical investigators say an ultrasound-microbubble-mediated system (Optison) enhances gene therapy targeting transforming growth factor (TGF)-beta in the kidneys of rodents.
"Transforming growth factor (TGF)-beta is a key mediator in renal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.